Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
Status:
Completed
Trial end date:
2001-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing. It
is not yet known whether giving fluorouracil into the liver is more effective than no further
treatment for patients with colon cancer undergoing surgery.
PURPOSE: This randomized phase III trial is studying giving infusions of fluorouracil into
the liver in treating patients with Dukes' A, Dukes' B, or Dukes' C colon cancer undergoing
surgery.
Phase:
Phase 3
Details
Lead Sponsor:
NSABP Foundation Inc
Collaborators:
National Cancer Institute (NCI) Northern California Cancer Center